Company / Shares Outstanding
Viridian Therapeutics, Inc.\DE Shares Outstanding History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
81.0M
FY2024
5-year range
11.9M / 81.0M
FY2020-FY2024
Trend
+81.0%
vs FY2023
Sector context
#118 of 212
Health Care
What the data says
At 80994046.00, Viridian Therapeutics, Inc.\DE's shares outstanding ranks #95 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 2089094.00 in FY2019 to 80994046.00 in FY2024.
Based on SEC 10-K filings.
80994046.00 in FY2024 with a 5-year CAGR of +107.8%.
Increased from 32087293.00 to 80994046.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +89.4%
- 5-Year CAGR
- +107.8%
- 10-Year CAGR
- -
Sector benchmark
#95 of 212 in Health CareTop 44% of 212This company 81.0M Sector average 306.7M
▼
-73.6% below sector average
Key checks
Key Insights
- Viridian Therapeutics, Inc.\DE's shares outstanding has grown for 5 consecutive years.
- In FY2024, shares outstanding increased 81.0% year-over-year.
- Ranks #118 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 81.0M | +81.0% |
| FY2023 | 44.8M | +39.5% |
| FY2022 | 32.1M | +169.2% |
| FY2021 | 11.9M | +235.1% |
| FY2020 | 3.6M | +70.3% |
| FY2019 | 2.1M | -92.9% |
| FY2018 | 29.6M | +3450.3% |
| FY2017 | 833.7K | +17.6% |
| FY2016 | 709.0K | -81.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026